-
282022.01
SCM Life Science, In line with the implementation of the Advanced Rege..
SCM Life Science, a bio-venture specializing in cell therapy (KOSDAQ 298060, CEO Lee Byung-gun, hereinafter SCM Life S..
-
282022.01
SCM Life Science, it will join hands with U.S. bio venture PBS Biotech..
SCM Life Science Co., Ltd. (KOSDAQ 298060 CEO Lee Byung-gun, SCM Life Science) will join hands with PBS Biotech Inc., ..
-
282022.01
SCM Life Science, R&D agreement with U.S. bio-venture TerraImmune on c..
SCM Life Science Co., Ltd. (KOSDAQ 298060 CEO Lee Byung-gun, hereinafter referred to as SCM Life Science) will join han..
-
282022.01
SCM Life Science, Subscription competition rate 814.91 to 1...The evid..
The public offering stock subscription rate of SCM Life Science Co., Ltd. (CEO Lee Byung-gun, hereinafter SCM Life Sci..
-
282022.01
Genexine and SCM Life Science Corporation Coimune, a U.S. corporation,..
CoImune, Inc., a U.S. joint venture between Genexine Co., Ltd. (CEO Sung Young-chul) and SCM Life Science Co., Ltd. (CE..
-
282022.01
SCM Life Science - Genexine. Coimune, an American corporation. Mergers..
CoImune, Inc., a U.S. joint venture between SCM Life Science Co., Ltd. (CEO Lee Byung-gun) and Genexine Co., Ltd. (CEO ..
-
282022.01
SCM Life Science has signed a contract to attract 4 billion won in sha..
SCM Life Science (hereinafter referred to as SCM Life Science, CEO Lee Byung-gun) signed a 4 billion won equity invest..
-
282022.01
SCM Life Science, A joint R&D agreement with Allele Biotech on diabete..
SCM Life Science (hereinafter referred to as SCM Life Science) signed a joint research and development agreement with ..
-
282022.01
SCM Life Science, Malaysian pharmaceutical company CCM Duofarma said, ..
SCM Life Science announced on the 25th that it has attracted 5.5 billion won worth of investment from CCM Duopharma Bio..